|
Name |
phomopchalasin C2
|
| Molecular Formula | C27H34N2O4 | |
| IUPAC Name* |
6-amino-4-benzyl-17,18-dihydroxy-7,13,15-trimethyl-10-oxa-3-azapentacyclo[13.2.2.01,5.08,19.011,18]nonadeca-6,14-dien-2-one
|
|
| SMILES |
CC1=CC(C)CC2OC3C(C)=C(N)C4C(Cc5ccccc5)NC(=O)C45C(O)C(O)C1C2C35
|
|
| InChI |
InChI=1S/C27H34N2O4/c1-12-9-13(2)18-19-17(10-12)33-24-14(3)22(28)20-16(11-15-7-5-4-6-8-15)29-26(32)27(20,21(19)24)25(31)23(18)30/h4-9,12,16-21,23-25,30-31H,10-11,28H2,1-3H3,(H,29,32)/t12-,16+,17-,18+,19+,20-,21+,23-,24+,25-,27-/m1/s1
|
|
| InChIKey |
JWQRTUMKGRZDKN-BZMOPKPVSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 450.58 | ALogp: | 1.9 |
| HBD: | 4 | HBA: | 5 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 104.8 | Aromatic Rings: | 6 |
| Heavy Atoms: | 33 | QED Weighted: | 0.519 |
| Caco-2 Permeability: | -5.09 | MDCK Permeability: | 0.00010861 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.303 |
| Human Intestinal Absorption (HIA): | 0.39 | 20% Bioavailability (F20%): | 0.075 |
| 30% Bioavailability (F30%): | 0.022 |
| Blood-Brain-Barrier Penetration (BBB): | 0.237 | Plasma Protein Binding (PPB): | 94.49% |
| Volume Distribution (VD): | 2.204 | Fu: | 4.54% |
| CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.155 |
| CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.772 |
| CYP2C9-inhibitor: | 0.017 | CYP2C9-substrate: | 0.108 |
| CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.265 |
| CYP3A4-inhibitor: | 0.572 | CYP3A4-substrate: | 0.55 |
| Clearance (CL): | 10.475 | Half-life (T1/2): | 0.026 |
| hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.465 |
| Drug-inuced Liver Injury (DILI): | 0.457 | AMES Toxicity: | 0.025 |
| Rat Oral Acute Toxicity: | 0.97 | Maximum Recommended Daily Dose: | 0.792 |
| Skin Sensitization: | 0.029 | Carcinogencity: | 0.04 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
| Respiratory Toxicity: | 0.954 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005127 | ![]() |
0.784 | D0SP3D | ![]() |
0.230 | ||
| ENC003936 | ![]() |
0.752 | D09NNH | ![]() |
0.229 | ||
| ENC003956 | ![]() |
0.611 | D0V3ZA | ![]() |
0.229 | ||
| ENC006060 | ![]() |
0.545 | D0IN7I | ![]() |
0.226 | ||
| ENC004543 | ![]() |
0.508 | D01XDL | ![]() |
0.226 | ||
| ENC003937 | ![]() |
0.488 | D02PAH | ![]() |
0.222 | ||
| ENC004368 | ![]() |
0.472 | D01TSI | ![]() |
0.222 | ||
| ENC005129 | ![]() |
0.472 | D0R1BD | ![]() |
0.220 | ||
| ENC005130 | ![]() |
0.472 | D05ZJG | ![]() |
0.217 | ||
| ENC005758 | ![]() |
0.460 | D0M6VK | ![]() |
0.217 | ||